What are the recommended CO2 (carbon dioxide) laser settings for treating Rhinophyma using a Candela device?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CO2 Laser Settings for Rhinophyma Treatment with Candela Device

For treating rhinophyma with a CO2 laser Candela device, use settings of 35-50 J/cm² with a 10-ms pulse duration for patients with Fitzpatrick skin types I-III, and 25-40 J/cm² with a 20-ms pulse duration for patients with skin types IV-VI. 1

Optimal Treatment Parameters

  • For continuous mode CO2 laser treatment (often used for debulking larger rhinophymas), use 10-20 W with a defocused 2-3 mm beam 2
  • For scanner-assisted treatment (used for reshaping nasal contours), use a 4-7 mm spot at 20-40 W 2
  • When using fractional ablative CO2 laser for milder cases, aggressive parameters of up to 70 mJ and 70% density with 16-18 passes have shown good results 3
  • Target endpoint should be delayed post-treatment perifollicular erythema and/or edema for effective tissue ablation 1

Treatment Approach Based on Severity

  • For mild rhinophyma:

    • Consider fractional CO2 laser treatment with settings of 70 mJ, 70% density, and multiple passes (16-18) 3, 4
    • This approach offers faster healing times with fewer adverse events while still providing good cosmetic outcomes 3
  • For moderate to severe rhinophyma:

    • Use continuous mode CO2 laser for initial debulking (10-20 W, defocused 2-3 mm beam) 2
    • Follow with scanner mode for reshaping and contouring (4-7 mm spot, 20-40 W) 2
    • Consider multiple sessions for optimal results in severe cases 5

Treatment Protocol

  • Administer appropriate anesthesia (1% lidocaine with epinephrine for regional perinasal nerve block) 3
  • Consider HSV prophylaxis with acyclovir 400 mg TID or valacyclovir 500 mg BID 3
  • Begin treatment with the appropriate mode based on severity assessment 2
  • For optimal results, include a margin of approximately 1 cm of normal skin in the treatment field 1
  • Allow re-epithelialization to occur naturally (typically 4-7 days) 3

Expected Outcomes and Follow-up

  • Expect complete re-epithelialization within 4-7 days post-treatment 3
  • Self-limited edema and erythema are normal in the immediate post-treatment period 3
  • Schedule follow-up at 3 months to assess results 2
  • Scanner-assisted CO2 laser treatment has shown only 1.1% recurrence in long-term follow-up studies 6

Potential Complications and Considerations

  • Main complications include pain during anesthetic injection, scarring, hypopigmentation (in approximately 3% of patients), and visible open pores 2
  • Traditional CO2 resurfacing may result in a shiny, scarred appearance with patulous pores and loss of pigmentation; fractional approaches may reduce these risks 3
  • For patients with significant telangiectasia, consider combination therapy with pulsed dye laser after CO2 treatment for optimal cosmetic results 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Carbon dioxide laser treatment of rhinophyma: a review of 124 patients.

The British journal of dermatology, 2009

Research

Laser surgery in rhinophyma.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2016

Guideline

Treatment of Rhinophyma Using CO2re Fractional Laser

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Surgical treatment of rhinophyma using carbon dioxide (CO2) laser and pulsed dye laser (PDL).

Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.